Goodwin (JD Supra Romania)
-
Roche Fined $14M for Undermining Biosimilar and Generic Competition in Romania
On January 15, 2020, the Romanian Competition Council fined fined Roche Romania SRL €12.9 million ($14.2 million) following two investigations into what the Competition Counsel found to be Roche’s anti-competitive practices related to its cancer drugs. In the first investigation, the Competition Council found that between 2017 and 2019 Roche adopted a commercial strategy aimed at eliminating...
Request a trial to view additional results